Thursday, March 03, 2011
GTx Ipsen team ends
Memphis-based GTx, backed by Pitt Hyde and others, yesterday announced the end of its toremifine collaboration with Ipsen, which had stepped into the partnership slot after Merck left. The MDN reports.
Labels:
drug development,
GTx Inc.,
Ipsen,
Merck Co.,
pharmaceuticals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment